Wesleyan appoints former LV= Group finance director to its Board
Wesleyan, the specialist financial services mutual for doctors, dentists, lawyers and teachers, today announced the appointment of Philip Moore to its board of directors. In his executive career, Philip was most recently group finance director for LV= until his retirement in 2017.
Philip, who is an actuary, has built a successful career in financial services spanning almost 40 years, including as chief finance officer and then chief executive officer of Friends Provident plc. He also spent nine years with PwC where he developed its life actuarial business in the UK and then as an insurance consulting partner in the firm’s East Asia business.
Since retiring from LV=, Philip has joined the Boards of Scandinavia’s third largest non-life insurance company Codan A/S, where he chairs the Audit and Risk Committee and Bank of Ireland (UK) plc where he chairs the Remuneration Committee.
Wesleyan chair Nathan Moss welcomed Philp to the Board saying: “Philip is a hugely experienced finance director and has a true understanding of the life insurance industry and, importantly for us, the particular opportunities and challenges facing mutual organisations. He is also a seasoned non- executive director.
“He will make a valuable contribution to the business as we put in place our ambitious growth plans while navigating through the challenging times ahead with the continuing impacts of the coronavirus pandemic.”
Philip added: “I am a passionate believer in the benefits of mutuality, and I’m delighted to join a business that demonstrates strong values and has an ambitious blueprint for growth while remaining true to its heritage.
“I am excited by the plans in place to unlock Wesleyan’s full potential, which will allow us to serve many more professional customers and put them front and centre of everything we do.”
Philip is also a Trustee of the Royal British Legion and a governor of Hart Learning Group which includes North Hertfordshire College.
Philip’s appointment is subject to regulatory approval.